Z-1074-2022 Class II Ongoing

Recalled by Daavlin Distributing Company — Bryan, OH

FDA device recall Z-1074-2022 was initiated by Daavlin Distributing Company on Apr 26, 2022 and is designated Class II. Reason for recall: Software issue, resuming an interrupted treatment will result in swap of utilized calibration treatment distance 0" inches to "9. Resulting in over or under dosing. The recall status is ongoing. Affected quantity: 1.

Recall details

Product Type
Devices
Report Date
May 18, 2022
Initiation Date
Apr 26, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1

Product description

4 Series CX phototherapy units equipped with Daavlin's ClearLink Control System software versions v3.03h and 3.04v. M4 Ser CX 311-20 120-240V 50/60Hz, item # 807QS0020CX6.

Reason for recall

Software issue, resuming an interrupted treatment will result in swap of utilized calibration treatment distance 0" inches to "9. Resulting in over or under dosing.

Distribution pattern

Worldwide distribution - US Nationwide distribution in the states of AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, MI, MN, MO, MS, MT, NC, NE, NH, NJ, NY, OH, OK, OR, PA, SD, TN, TX, VA, WA, WI, WV and the countries of Australia, Canada.

Code information

UDI-DI: +B2809807QS0020CX60L. Serial Number: QS11571PLNBCX0020

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1074-2022
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1074-2022. Report a data issue: hello@regdatalab.com.